Is the PANSS used correctly? a systematic review

被引:55
作者
Obermeier, Michael [1 ]
Schennach-Wolff, Rebecca [1 ]
Meyer, Sebastian [1 ]
Moeller, Hans-Juergen [1 ]
Riedel, Michael [1 ,2 ]
Krause, Daniela [1 ]
Seemueller, Florian [1 ]
机构
[1] Univ Munich, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany
[2] Vinzenz von Paul Hosp, D-78628 Rottweil, Germany
关键词
PANSS; scale level; literature search; PALIPERIDONE EXTENDED-RELEASE; ANTIPSYCHOTIC TREATMENT RESPONSE; DOUBLE-BLIND; OPEN-LABEL; SCHIZOAFFECTIVE DISORDER; SCHIZOPHRENIC-PATIENTS; GENE POLYMORPHISMS; RISPERIDONE; EFFICACY; OLANZAPINE;
D O I
10.1186/1471-244X-11-113
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The PANSS (Positive and Negative Syndrome Scale) is one of the most important rating instruments for patients with schizophrenia. Nevertheless, there is a long and ongoing debate in the psychiatric community regarding its mathematical properties. All 30 items range from 1 to 7 leading to a minimum total score of 30, implying that the PANSS is an interval scale. For such interval scales straightforward calculation of relative changes is not appropriate. To calculate outcome criteria based on a percent change as, e.g., the widely accepted response criterion, the scale has to be transformed into a ratio scale beforehand. Recent publications have already pointed out the pitfall that ignoring the scale level (interval vs. ratio scale) leads to a set of mathematical problems, potentially resulting in erroneous results concerning the efficacy of the treatment. Methods: A Pubmed search based on the PRISMA statement of the highest-ranked psychiatric journals (search terms "PANSS" and "response") was carried out. All articles containing percent changes were included and methods of percent change calculation were analysed. Results: This systematic literature research shows that the majority of authors (62%) actually appear to use incorrect calculations. In most instances the method of calculation was not described in the manuscript. Conclusions: These alarming results underline the need for standardized procedures for PANSS calculations.
引用
收藏
页数:5
相关论文
共 46 条
  • [1] [Anonymous], J PSYCHIAT RES
  • [2] [Anonymous], PSYCHOL MED
  • [3] [Anonymous], SCHIZOPHR B
  • [4] [Anonymous], 021253 FDA
  • [5] Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients
    Bozina, Nada
    Kuzman, Martina Roinic
    Medved, Vesna
    Jovanovic, Nikolina
    Sertic, Jadranka
    Hotujac, Ljubomir
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (02) : 89 - 97
  • [6] A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia
    Breier, A
    Meehan, K
    Birkett, M
    David, S
    Ferchland, I
    Sutton, V
    Taylor, CC
    Palmer, R
    Dossenbach, M
    Kiesler, G
    Brook, S
    Wright, P
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (05) : 441 - 448
  • [7] Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia
    Campbell, Daniel B.
    Ebert, Philip J.
    Skelly, Tara
    Stroup, T. Scott
    Lieberman, Jeffrey
    Levitt, Pat
    Sullivan, Patrick F.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (01) : 32 - 41
  • [8] A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder
    Canuso, Carla M.
    Lindenmayer, Jean-Pierre
    Kosik-Gonzalez, Colette
    Turkoz, Ibrahim
    Carothers, Jennifer
    Bossie, Cynthia A.
    Schooler, Nina R.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (05) : 587 - 598
  • [9] Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: A Randomized trial
    Chan, Hung-Yu
    Lin, Wei-Wen
    Lin, Shih-Ku
    Hwang, Tzung-Jeng
    Su, Tung-Ping T.
    Chiang, Shu-Chuan
    Hwu, Hai-Gwo
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (01) : 29 - 36
  • [10] A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia
    Copolov, DL
    Link, CGG
    Kowalcyk, B
    [J]. PSYCHOLOGICAL MEDICINE, 2000, 30 (01) : 95 - 105